Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MC0704 is a STAT3 inhibitor that demonstrates antitumor activity specifically in mouse breast cancer models, possessing an IC50 value of 2.13 μM. It is effective in inducing cell apoptosis and cell cycle arrest, making it a potential candidate for researching metastatic triple-negative breast cancer (mTNBC).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | MC0704 is a STAT3 inhibitor that demonstrates antitumor activity specifically in mouse breast cancer models, possessing an IC50 value of 2.13 μM. It is effective in inducing cell apoptosis and cell cycle arrest, making it a potential candidate for researching metastatic triple-negative breast cancer (mTNBC). |
分子量 | 537.41 |
分子式 | C29H21BrN4O2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MC0704 Inhibitor inhibitor inhibit